Skip to main content
padlock icon - secure page this page is secure

Publisher: Wolters Kluwer

Volume 28, Number 11, November 2018

Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial
pp. 245-250(6)
Authors: Ruiz-Pinto, Sara; Martin, Miguel; Pita, Guillermo; Caronia, Daniela; de la Torre-Montero, Julio C.; Moreno, Leticia T.; Moreno, Fernando; García-Sáenz, José Á.; Benítez, Javier; González-Neira, Anna


Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide
pp. 251-255(5)
Authors: Singh, Sonal; Wang, Zhiying; Shahin, Mohamed H.; Langaee, Taimour Y.; Gong, Yan; Turner, Stephen T.; Chapman, Arlene B.; Gums, John G.; McDonough, Caitrin W.; Bailey, Kent R.; Beitelshees, Amber L.; Cooper-DeHoff, Rhonda M.; Scherer, Steve; Boerwinkle, Eric; Johnson, Julie A.


Leveraging electronic health records to assess the role of ADRB2 single nucleotide polymorphisms in predicting exacerbation frequency in asthma patients
pp. 256-259(4)
Authors: Sood, Nikita; Connolly, John J.; Mentch, Frank D.; Vazquez, Lyam; Sleiman, Patrick M.A.; Hysinger, Erik B.; Hakonarson, Hakon


  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more